Deutsche Bank AG increased its holdings in American Vanguard Corp. (NYSE:AVD) by 22.7% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 83,238 shares of the basic materials company’s stock after acquiring an additional 15,379 shares during the period. Deutsche Bank AG’s holdings in American Vanguard were worth $1,262,000 at the end of the most recent quarter.
A number of other institutional investors have also modified their holdings of the stock. Bank of New York Mellon Corp lifted its stake in American Vanguard by 2.3% during the 3rd quarter. Bank of New York Mellon Corp now owns 463,778 shares of the basic materials company’s stock valued at $8,348,000 after acquiring an additional 10,596 shares in the last quarter. MetLife Investment Advisors LLC lifted its stake in American Vanguard by 54.0% during the 3rd quarter. MetLife Investment Advisors LLC now owns 22,919 shares of the basic materials company’s stock valued at $413,000 after acquiring an additional 8,032 shares in the last quarter. Legal & General Group Plc lifted its stake in American Vanguard by 8.8% during the 3rd quarter. Legal & General Group Plc now owns 57,001 shares of the basic materials company’s stock valued at $1,047,000 after acquiring an additional 4,626 shares in the last quarter. Morgan Stanley lifted its stake in American Vanguard by 15.1% during the 3rd quarter. Morgan Stanley now owns 171,880 shares of the basic materials company’s stock valued at $3,094,000 after acquiring an additional 22,557 shares in the last quarter. Finally, Vanguard Group Inc. lifted its stake in American Vanguard by 3.5% during the 3rd quarter. Vanguard Group Inc. now owns 2,737,677 shares of the basic materials company’s stock valued at $49,278,000 after acquiring an additional 93,491 shares in the last quarter. Institutional investors own 77.44% of the company’s stock.
In other news, insider John Rizzi sold 7,470 shares of American Vanguard stock in a transaction on Friday, March 15th. The stock was sold at an average price of $18.43, for a total transaction of $137,672.10. Following the sale, the insider now directly owns 43,072 shares in the company, valued at approximately $793,816.96. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 5.20% of the company’s stock.
NYSE AVD opened at $14.86 on Friday. The firm has a market cap of $441.19 million, a PE ratio of 18.35 and a beta of 1.19. American Vanguard Corp. has a one year low of $13.98 and a one year high of $23.90. The company has a current ratio of 2.31, a quick ratio of 1.03 and a debt-to-equity ratio of 0.47.
American Vanguard (NYSE:AVD) last released its earnings results on Tuesday, May 7th. The basic materials company reported $0.13 EPS for the quarter, topping the Zacks’ consensus estimate of $0.12 by $0.01. The company had revenue of $99.70 million for the quarter, compared to analysts’ expectations of $105.20 million. American Vanguard had a return on equity of 7.17% and a net margin of 5.21%. The business’s revenue for the quarter was down 4.2% compared to the same quarter last year. During the same period in the previous year, the business posted $0.16 EPS. As a group, sell-side analysts forecast that American Vanguard Corp. will post 0.81 EPS for the current fiscal year.
TRADEMARK VIOLATION NOTICE: “Deutsche Bank AG Has $1.26 Million Position in American Vanguard Corp. (AVD)” was first posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are viewing this report on another publication, it was stolen and reposted in violation of international trademark & copyright legislation. The correct version of this report can be viewed at https://www.baseballdailydigest.com/news/2019/05/12/deutsche-bank-ag-has-1-26-million-position-in-american-vanguard-corp-avd.html.
American Vanguard Company Profile
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. The company manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.
Recommended Story: Why is a lock-up period needed for an IPO?
Want to see what other hedge funds are holding AVD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for American Vanguard Corp. (NYSE:AVD).
Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.